Skov J, Pedersen M, Holst JJ, Madsen B, Goetze JP, Rittig S, Jonassen T, Frkiaer J, Dejgaard A, Christiansen JS
Hepatic Benefits Potentially reduces the incidence of metabolic liver diseases
They found that users leveraging their wearables via Vitals Wearables API achieved their weight loss goals 24% faster than those who didn't
Concomitant administration of the drug with drugs that induce hypocarnitinemia due to increased loss of renal carnitine (valproic acid, prodrugs containing pivalic acid, cephalosporins, cisplatin, carboplatin and ifosfamide) can reduce the availability of L-carnitine
Under the influence of IL-4 and IL-13 and the interactions between adhesion molecules on B cells (class II MHC molecules: CD80/CD86, CD40, and ICAM-1) and T cells (CD3, CD4, CD28, CD40L, and LFA-1 receptors), B cells switch from expressing IgM, IgG2, and IgG3 to IgG4 and IgE (179)
One of the biggest concerns discussed in the video is the unknown long-term risk of stimulating growth pathways in the body
